Histology And Cytology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Report Summary

GlobalData’s new report, “Histology And Cytology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017” provides key market data on the Histology And Cytology market in the BRICS countries. The report provides value ($m) data for each segment and sub-segment within three market categories – Tissue Typing Reagents, Flow Cytometers and Monoclonal Antibodies. The report also provides company shares and distribution shares data for the overall Histology And Cytology market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world’s most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It’s estimated that shortly after 2020, India’s population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.

Scope

• Market size data for Histology And Cytology market categories – Tissue Typing Reagents, Flow Cytometers and Monoclonal Antibodies.
• Annualized market revenues ($m) data for each of the segments and sub-segments within the three market categories. Data from 2003 to 2010, forecast forward for seven years to 2017.
• 2010 company shares and distribution shares data for the overall Histology And Cytology market in each of the aforementioned countries.
• Global corporate-level profiles of key companies operating within the Histology And Cytology market in BRICS.
• Key players covered include Becton, Dickinson and Company, Beckman Coulter, Inc., Sysmex Corporation, F. Hoffmann-La Roche Ltd., Life Technologies Corporation, Bio-Rad Laboratories, Inc., Abbott Laboratories and Danaher Corporation.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Histology And Cytology competitive landscape in BRICS.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table of Contents

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8

2 Introduction 10
2.1 What is This Report About? 10

3 Histology And Cytology in BRICS 11
3.1 Histology And Cytology, BRICS, Overall Revenue ($m), 2003-2017 11
3.2 Histology And Cytology, BRICS, Company share (2009-2010) 17

4 Histology And Cytology In Brazil 19
4.1 Histology And Cytology, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 19
4.2 Tissue Typing Reagents In Brazil 25
4.2.1 Tissue Typing Reagents, Brazil, Overall Revenue (2003-2017) 25
4.3 Monoclonal Antibodies In Brazil 27
4.3.1 Monoclonal Antibodies, Brazil, Overall Revenue (2003-2017) 27
4.4 Flow Cytometers In Brazil 29
4.4.1 Flow Cytometers, Brazil, Overall Revenue (2003-2017) 29
4.5 Histology And Cytology, Brazil, Distribution Share (2009-2010) 31
4.6 Histology And Cytology, Brazil, Company Share (2009-2010) 32

5 Histology And Cytology In Russian Federation 34
5.1 Histology And Cytology, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 34
5.2 Tissue Typing Reagents In Russian Federation 40
5.2.1 Tissue Typing Reagents, Russian Federation, Overall Revenue (2003-2017) 40
5.3 Flow Cytometers In Russian Federation 42
5.3.1 Flow Cytometers, Russian Federation, Overall Revenue (2003-2017) 42
5.4 Monoclonal Antibodies In Russian Federation 44
5.4.1 Monoclonal Antibodies, Russian Federation, Overall Revenue (2003-2017) 44
5.5 Histology And Cytology, Russian Federation, Distribution Share (2009-2010) 46
5.6 Histology And Cytology, Russian Federation, Company Share (2009-2010) 47

6 Histology And Cytology In India 49
6.1 Histology And Cytology, India, Overall Revenue ($m), USD Actual, 2003-2017 49
6.2 Tissue Typing Reagents In India 55
6.2.1 Tissue Typing Reagents, India, Overall Revenue (2003-2017) 55
6.3 Flow Cytometers In India 57
6.3.1 Flow Cytometers, India, Overall Revenue (2003-2017) 57
6.4 Monoclonal Antibodies In India 59
6.4.1 Monoclonal Antibodies, India, Overall Revenue (2003-2017) 59
6.5 Histology And Cytology, India, Distribution Share (2009-2010) 61
6.6 Histology And Cytology, India, Company Share (2009-2010) 62

7 Histology And Cytology In China 64
7.1 Histology And Cytology, China, Overall Revenue ($m), USD Actual, 2003-2017 64
7.2 Flow Cytometers In China 70
7.2.1 Flow Cytometers, China, Overall Revenue (2003-2017) 70
7.3 Tissue Typing Reagents In China 72
7.3.1 Tissue Typing Reagents, China, Overall Revenue (2003-2017) 72
7.4 Monoclonal Antibodies In China 74
7.4.1 Monoclonal Antibodies, China, Overall Revenue (2003-2017) 74
7.5 Histology And Cytology, China, Distribution Share (2009-2010) 76
7.6 Histology And Cytology, China, Company share (2009-2010) 77

8 Histology And Cytology In South Africa 79
8.1 Histology And Cytology, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 79
8.2 Tissue Typing Reagents In South Africa 84
8.2.1 Tissue Typing Reagents, South Africa, Overall Revenue (2003-2017) 84
8.3 Flow Cytometers In South Africa 86
8.3.1 Flow Cytometers, South Africa, Overall Revenue (2003-2017) 86
8.4 Monoclonal Antibodies In South Africa 88
8.4.1 Monoclonal Antibodies, South Africa, Overall Revenue (2003-2017) 88
8.5 Histology And Cytology, South Africa, Distribution Share (2009-2010) 90
8.6 Histology And Cytology, South Africa, Company share (2009-2010) 91

9 Overview of Key Companies in BRICS Histology And Cytology Market 93
9.1 Becton, Dickinson and Company 93
9.1.1 Company Overview 93
9.1.2 Share in the BRICS Histology And Cytology Market 94
9.2 Beckman Coulter, Inc. 95
9.2.1 Company Overview 95
9.2.2 Share in the BRICS Histology And Cytology Market 96
9.3 Sysmex Corporation 97
9.3.1 Company Overview 97
9.3.2 Share in the BRICS Histology And Cytology Market 98
9.4 F. Hoffmann-La Roche Ltd. 99
9.4.1 Company Overview 99
9.4.2 Share in the BRICS Histology And Cytology Market 100
9.5 Life Technologies Corporation 101
9.5.1 Company Overview 101
9.5.2 Share in the BRICS Histology And Cytology Market 102
9.6 Bio-Rad Laboratories, Inc. 103
9.6.1 Company Overview 103
9.6.2 Share in the BRICS Histology And Cytology Market 104
9.7 Abbott Laboratories 105
9.7.1 Company Overview 105
9.7.2 Share in the BRICS Histology And Cytology Market 106
9.8 Danaher Corporation 107
9.8.1 Company Overview 107
9.8.2 Share in the BRICS Histology And Cytology Market 108
9.9 Hologic, Inc. 109
9.9.1 Company Overview 109
9.10 Trivitron Healthcare Pvt Ltd. 109
9.10.1 Company Overview 109
9.11 Thermo Fisher Scientific Inc. 109
9.11.1 Company Overview 109

10 Appendix 110
10.1 Definitions of Markets Covered in the Report 111
10.1.1 Histology And Cytology 111
10.2 Research Methodology 112
10.3 Secondary Research 112
10.4 Primary Research 113
10.5 Models 113
10.6 Forecasts 114
10.7 Expert Panels 114
10.8 GlobalData Consulting 114
10.9 Currency Conversion 115
10.10 Contact Us 115
10.11 Disclaimer 115

List of Tables

Table 1: Histology And Cytology, BRICS, Overall Revenue ($m), 2003-2017 12
Table 2: Histology And Cytology, BRICS, Overall Revenue ($m), Historic, 2003-2010 14
Table 3: Histology And Cytology, BRICS, Overall Revenue ($m), Forecast, 2010-2017 16
Table 4: Histology And Cytology, BRICS, Company share by Revenue ($m), USD Actual, 2009-2010 18
Table 5: Histology And Cytology, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 20
Table 6: Histology And Cytology, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 22
Table 7: Histology And Cytology, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 24
Table 8: Tissue Typing Reagents, Brazil, Revenue ($m), Historic, 2003-2010 25
Table 9: Tissue Typing Reagents, Brazil, Revenue ($m), Forecast, 2010-2017 26
Table 10: Monoclonal Antibodies, Brazil, Revenue ($m), Historic, 2003-2010 27
Table 11: Monoclonal Antibodies, Brazil, Revenue ($m), Forecast, 2010-2017 28
Table 12: Flow Cytometers, Brazil, Revenue ($m), Historic, 2003-2010 29
Table 13: Flow Cytometers, Brazil, Revenue ($m), Forecast, 2010-2017 30
Table 14: Histology And Cytology, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 31
Table 15: Histology And Cytology, Brazil, Company share by Revenue ($m), USD Actual, 2009-2010 33
Table 16: Histology And Cytology, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 35
Table 17: Histology And Cytology, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 37
Table 18: Histology And Cytology, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 39
Table 19: Tissue Typing Reagents, Russian Federation, Revenue ($m), Historic, 2003-2010 40
Table 20: Tissue Typing Reagents, Russian Federation, Revenue ($m), Forecast, 2010-2017 41
Table 21: Flow Cytometers, Russian Federation, Revenue ($m), Historic, 2003-2010 42
Table 22: Flow Cytometers, Russian Federation, Revenue ($m), Forecast, 2010-2017 43
Table 23: Monoclonal Antibodies, Russian Federation, Revenue ($m), Historic, 2003-2010 44
Table 24: Monoclonal Antibodies, Russian Federation, Revenue ($m), Forecast, 2010-2017 45
Table 25: Histology And Cytology, Russian Federation, Distribution Share by Revenue ($m), USD Actual, 2009-2010 46
Table 26: Histology And Cytology, Russian Federation, Company share by Revenue ($m), USD Actual, 2009-2010 48
Table 27: Histology And Cytology, India, Overall Revenue ($m), USD Actual, 2003-2017 50
Table 28: Histology And Cytology, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 52
Table 29: Histology And Cytology, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 54
Table 30: Tissue Typing Reagents, India, Revenue ($m), Historic, 2003-2010 55
Table 31: Tissue Typing Reagents, India, Revenue ($m), Forecast, 2010-2017 56
Table 32: Flow Cytometers, India, Revenue ($m), Historic, 2003-2010 57
Table 33: Flow Cytometers, India, Revenue ($m), Forecast, 2010-2017 58
Table 34: Monoclonal Antibodies, India, Revenue ($m), Historic, 2003-2010 59
Table 35: Monoclonal Antibodies, India, Revenue ($m), Forecast, 2010-2017 60
Table 36: Histology And Cytology, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010 61
Table 37: Histology And Cytology, India, Company Share by Revenue ($m), USD Actual 2009-2010 63
Table 38: Histology And Cytology, China, Overall Revenue ($m), USD Actual, 2003-2017 65
Table 39: Histology And Cytology, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 67
Table 40: Histology And Cytology, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 69
Table 41: Flow Cytometers, China, Revenue ($m), Historic, 2003-2010 70
Table 42: Flow Cytometers, China, Revenue ($m), Forecast, 2010-2017 71
Table 43: Tissue Typing Reagents, China, Revenue ($m), Historic, 2003-2010 72
Table 44: Tissue Typing Reagents, China, Revenue ($m), Forecast, 2010-2017 73
Table 45: Monoclonal Antibodies, China, Revenue ($m), Historic, 2003-2010 74
Table 46: Monoclonal Antibodies, China, Revenue ($m), Forecast, 2010-2017 75
Table 47: Histology And Cytology, China, Distribution Share by Revenue ($m), USD Actual, 2009-2010 76
Table 48: Histology And Cytology, China, Company share by Revenue ($m), USD Actual 2009-2010 78
Table 49: Histology And Cytology, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 79
Table 50: Histology And Cytology, South Africa, Overall Revenue ($m), USD Actual, Historic, 2003-2010 81
Table 51: Histology And Cytology, South Africa, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 83
Table 52: Tissue Typing Reagents, South Africa, Revenue ($m) , Historic, 2003-2010 84
Table 53: Tissue Typing Reagents, South Africa, Revenue ($m), Forecast, 2010-2017 85
Table 54: Flow Cytometers, South Africa, Revenue ($m), Historic, 2003-2010 86
Table 55: Flow Cytometers, South Africa, Revenue ($m), Forecast, 2010-2017 87
Table 56: Monoclonal Antibodies, South Africa, Revenue ($m), Historic, 2003-2010 88
Table 57: Monoclonal Antibodies, South Africa, Revenue ($m), Forecast, 2010-2017 89
Table 58: Histology And Cytology, South Africa, Distribution Share by Revenue ($m), USD Actual, 2009-2010 90
Table 59: Histology And Cytology, South Africa, Company share by Revenue ($m), USD Actual 2009-2010 92
Table 60: Becton, Dickinson and Company, Revenue ($m), BRICS Histology And Cytology Market, 2010 94
Table 61: Beckman Coulter, Inc., Revenue ($m), BRICS Histology And Cytology Market, 2010 96
Table 62: Sysmex Corporation, Revenue ($m), BRICS Histology And Cytology Market, 2010 98
Table 63: F. Hoffmann-La Roche Ltd., Revenue ($m), BRICS Histology And Cytology Market, 2010 100
Table 64: Life Technologies Corporation, Revenue ($m), BRICS Histology And Cytology Market, 2010 102
Table 65: Bio-Rad Laboratories, Inc., Revenue ($m), BRICS Histology And Cytology Market, 2010 104
Table 66: Abbott Laboratories, Revenue ($m), BRICS Histology And Cytology Market, 2010 106
Table 67: Danaher Corporation, Revenue ($m), BRICS Histology And Cytology Market, 2010 108
Table 68: USD to Local Currency, BRICS, Average Exchange Rate, 2003-2010 115

List of Figures

Figure 1: Histology And Cytology, BRICS, Overall Revenue ($m), 2003-2017 11
Figure 2: Histology And Cytology, BRICS, Overall Revenue ($m), Historic, 2003-2010 13
Figure 3: Histology And Cytology, BRICS, Overall Revenue ($m), Forecast, 2010-2017 15
Figure 4: Histology And Cytology, BRICS, Company share (%), 2010 17
Figure 5: Histology And Cytology, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 19
Figure 6: Histology And Cytology, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 21
Figure 7: Histology And Cytology, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 23
Figure 8: Tissue Typing Reagents, Brazil, Revenue ($m), Historic, 2003-2010 25
Figure 9: Tissue Typing Reagents, Brazil, Revenue ($m), Forecast, 2010-2017 26
Figure 10: Monoclonal Antibodies, Brazil, Revenue ($m), Historic, 2003-2010 27
Figure 11: Monoclonal Antibodies, Brazil, Revenue ($m), Forecast, 2010-2017 28
Figure 12: Flow Cytometers, Brazil, Revenue ($m), Historic, 2003-2010 29
Figure 13: Flow Cytometers, Brazil, Revenue ($m), Forecast, 2010-2017 30
Figure 14: Histology And Cytology, Brazil, Company share (%), 2010 32
Figure 15: Histology And Cytology, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 34
Figure 16: Histology And Cytology, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 36
Figure 17: Histology And Cytology, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 38
Figure 18: Tissue Typing Reagents, Russian Federation, Revenue ($m), Historic, 2003-2010 40
Figure 19: Tissue Typing Reagents, Russian Federation, Revenue ($m), Forecast, 2010-2017 41
Figure 20: Flow Cytometers, Russian Federation, Revenue ($m), Historic, 2003-2010 42
Figure 21: Flow Cytometers, Russian Federation, Revenue ($m), Forecast, 2010-2017 43
Figure 22: Monoclonal Antibodies, Russian Federation, Revenue ($m), Historic, 2003-2010 44
Figure 23: Monoclonal Antibodies, Russian Federation, Revenue ($m), Forecast, 2010-2017 45
Figure 24: Histology And Cytology, Russian Federation, Company share (%), 2010 47
Figure 25: Histology And Cytology, India, Overall Revenue ($m), USD Actual, 2003-2017 49
Figure 26: Histology And Cytology, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 51
Figure 27: Histology And Cytology, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 53
Figure 28: Tissue Typing Reagents, India, Revenue ($m), Historic, 2003-2010 55
Figure 29: Tissue Typing Reagents, India, Revenue ($m), Forecast, 2010-2017 56
Figure 30: Flow Cytometers, India, Revenue ($m), Historic, 2003-2010 57
Figure 31: Flow Cytometers, India, Revenue ($m), Forecast, 2010-2017 58
Figure 32: Monoclonal Antibodies, India, Revenue ($m), Historic, 2003-2010 59
Figure 33: Monoclonal Antibodies, India, Revenue ($m), Forecast, 2010-2017 60
Figure 34: Histology And Cytology, India, Company Share (%), 2010 62
Figure 35: Histology And Cytology, China, Overall Revenue ($m), USD Actual, 2003-2017 64
Figure 36: Histology And Cytology, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 66
Figure 37: Histology And Cytology, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 68
Figure 38: Flow Cytometers, China, Revenue ($m), Historic, 2003-2010 70
Figure 39: Flow Cytometers, China, Revenue ($m), Forecast, 2010-2017 71
Figure 40: Tissue Typing Reagents, China, Revenue ($m), Historic, 2003-2010 72
Figure 41: Tissue Typing Reagents, China, Revenue ($m), Forecast, 2010-2017 73
Figure 42: Monoclonal Antibodies, China, Revenue ($m), Historic, 2003-2010 74
Figure 43: Monoclonal Antibodies, China, Revenue ($m), Forecast, 2010-2017 75
Figure 44: Histology And Cytology, China, Company share (%), 2010 77
Figure 45: Histology And Cytology, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 79
Figure 46: Histology And Cytology, South Africa, Overall Revenue ($m), USD Actual, Historic, 2003-2010 80
Figure 47: Histology And Cytology, South Africa, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 82
Figure 48: Tissue Typing Reagents, South Africa, Revenue ($m), Historic, 2003-2010 84
Figure 49: Tissue Typing Reagents, South Africa, Revenue ($m), Forecast, 2010-2017 85
Figure 50: Flow Cytometers, South Africa, Revenue ($m), Historic, 2003-2010 86
Figure 51: Flow Cytometers, South Africa, Revenue ($m), Forecast, 2010-2017 87
Figure 52: Monoclonal Antibodies, South Africa, Revenue ($m), Historic, 2003-2010 88
Figure 53: Monoclonal Antibodies, South Africa, Revenue ($m), Forecast, 2010-2017 89
Figure 54: Histology And Cytology, South Africa, Company share (%), 2010 91
Figure 55: Becton, Dickinson and Company, Company Share (%), BRICS Histology And Cytology Market, 2010 94
Figure 56: Beckman Coulter, Inc., Company Share (%), BRICS Histology And Cytology Market, 2010 96
Figure 57: Sysmex Corporation, Company Share (%), BRICS Histology And Cytology Market, 2010 98
Figure 58: F. Hoffmann-La Roche Ltd., Company Share (%), BRICS Histology And Cytology Market, 2010 100
Figure 59: Life Technologies Corporation, Company Share (%), BRICS Histology And Cytology Market, 2010 102
Figure 60: Bio-Rad Laboratories, Inc., Company Share (%), BRICS Histology And Cytology Market, 2010 104
Figure 61: Abbott Laboratories, Company Share (%), BRICS Histology And Cytology Market, 2010 106
Figure 62: Danaher Corporation, Company Share (%), BRICS Histology And Cytology Market, 2010 108